Jiangsu Hengrui Pharmaceuticals Co., Ltd.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE0000014W7
CNY
53.52
0.72 (1.36%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Net Sales
8,140.57
8,441.33
7,426.89
8,555.58
7,205.61
7,795.30
6,588.57
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
8,140.57
8,441.33
7,426.89
8,555.58
7,205.61
7,795.30
6,588.57
Raw Material Cost
1,090.95
1,263.68
1,176.95
1,147.04
1,169.40
1,105.25
1,050.13
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.45
2.00
0.69
0.74
10.92
2.25
0.00
Selling and Distribution Expenses
2,824.33
2,979.67
3,234.06
3,098.20
2,525.13
2,846.60
2,829.51
Other Expenses
165.02
194.65
164.93
161.39
144.22
196.00
143.93
Total Expenditure (Excl Depreciation)
5,565.90
6,191.82
6,061.02
5,859.86
5,147.63
5,914.11
5,318.97
Operating Profit (PBDIT) excl Other Income
2574.7000000000003
2249.5
1365.9
2695.7
2058
1881.2
1269.6
Other Income
-9.51
150.26
104.26
244.48
127.96
199.51
147.43
Operating Profit (PBDIT)
2,486.35
2,503.82
1,629.60
3,099.21
2,355.38
2,176.45
1,576.00
Interest
0.45
2.00
0.69
0.74
10.92
2.25
0.00
Exceptional Items
129.06
75.77
-13.46
124.38
-13.11
99.10
1.99
Gross Profit (PBDT)
7,049.62
7,177.65
6,249.94
7,408.54
6,036.21
6,690.05
5,538.44
Depreciation
0.00
240.34
240.34
230.90
230.90
223.00
223.00
Profit Before Tax
2,614.96
2,337.26
1,375.11
2,991.95
2,100.45
2,050.30
1,354.99
Tax
275.87
338.85
55.51
397.10
199.16
362.29
146.94
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
2,282.27
1,959.89
1,301.06
2,576.05
1,874.06
1,716.95
1,187.83
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
2,282.27
1,959.89
1,301.06
2,576.05
1,874.06
1,716.95
1,187.83
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-1.27
-3.12
4.50
2.18
2.39
3.71
0.37
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
2,280.99
1,956.77
1,305.56
2,578.23
1,876.44
1,720.66
1,188.20
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
63,626.26
61,272.07
59,504.25
58,464.83
46,987.06
45,519.86
43,767.91
Earnings per share (EPS)
0.35
0.29
0.2
0.4
0.3
0.27
0.19
Diluted Earnings per share
0.35
0.29
0.2
0.4
0.3
0.27
0.19
Operating Profit Margin (Excl OI)
30.66%
25.03%
17.3%
30.67%
27.71%
22.5%
18.3%
Gross Profit Margin
32.12%
30.54%
21.75%
37.67%
32.35%
29.16%
23.95%
PAT Margin
28.04%
23.22%
17.52%
30.11%
26.01%
22.03%
18.03%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Mar 2026 is -3.56% vs 13.66% in Dec 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Mar 2026 is 16.57% vs 49.88% in Dec 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Mar 2026 is 6.05% vs 54.30% in Dec 2025

stock-summary

Interest

QoQ Growth in quarter ended Mar 2026 is -80.00% vs 185.71% in Dec 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025

Compare Quarterly Results Of Jiangsu Hengrui Pharmaceuticals Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
8,140.57
0
8,140.57
Other Operating Income
0.00
0.00
0.00
Total Operating income
8,140.57
0
8,140.57
Raw Material Cost
1,090.95
0
1,090.95
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
0.45
0
0.45
Selling and Distribution Expenses
2,824.33
0
2,824.33
Other Expenses
165.02
0.00
165.02
Total Expenditure (Excl Depreciation)
5,565.90
0
5,565.90
Operating Profit (PBDIT) excl Other Income
2,574.66
0.00
2,574.66
Other Income
-9.51
0
-9.51
Operating Profit (PBDIT)
2,486.35
0
2,486.35
Interest
0.45
0
0.45
Exceptional Items
129.06
0
129.06
Gross Profit (PBDT)
7,049.62
0
7,049.62
Depreciation
0.00
0
0.00
Profit Before Tax
2,614.96
0
2,614.96
Tax
275.87
0
275.87
Provisions and contingencies
0
0
0.00
Profit After Tax
2,282.27
0
2,282.27
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
2,282.27
0
2,282.27
Share in Profit of Associates
0
0
0.00
Minority Interest
-1.27
0
-1.27
Other related items
0.00
0.00
0.00
Consolidated Net Profit
2,280.99
0
2,280.99
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
63,626.26
0
63,626.26
Earnings per share (EPS)
0.35
0
0.35
Diluted Earnings per share
0.35
0
0.35
Operating Profit Margin (Excl OI)
30.66%
0%
0.00
30.66%
Gross Profit Margin
32.12%
0%
0.00
32.12%
PAT Margin
28.04%
0%
0.00
28.04%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 814.06 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is -3.56% vs 13.66% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 12.98% vs 20.14% in Mar 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit 228.10 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is 16.57% vs 49.88% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 21.56% vs 37.21% in Mar 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 249.59 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is 6.05% vs 54.30% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 12.05% vs 36.19% in Mar 2025

Quarterly - Interest
Interest 0.04 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is -80.00% vs 185.71% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is -96.33% vs 0.00% in Mar 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 30.66%
in Mar 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 has improved from Mar 2025